Chris Freeman's most recent trade in Guardant Health Inc was a trade of 15,428 Performance-Based Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 15,428 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 15,428 | 44,151 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 01 Jan 2026 | 10,162 | 43,870 (0%) | 0% | 102.1 | 1,037,947 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 5,688 | 51,506 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 5,688 | 5,688 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 2,526 | 54,032 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 2,526 | 17,684 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 1,928 | 5,786 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 1,928 | 28,723 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 1,667 | 45,818 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 1,667 | 5,002 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 1,402 | 27,389 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 1,402 | 2,804 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.67 per share. | 15 Dec 2025 | 594 | 26,795 (0%) | 0% | 102.7 | 60,986 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 102.09 per share. | 05 Dec 2025 | 11,969 | 39,320 (0%) | 0% | 102.1 | 1,221,970 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 103.97 per share. | 05 Dec 2025 | 6,555 | 29,351 (0%) | 0% | 104.0 | 681,534 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 101.40 per share. | 05 Dec 2025 | 4,084 | 51,289 (0%) | 0% | 101.4 | 414,129 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 103.25 per share. | 05 Dec 2025 | 3,414 | 35,906 (0%) | 0% | 103.3 | 352,505 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 106.71 per share. | 05 Dec 2025 | 2,964 | 25,987 (0%) | 0% | 106.7 | 316,283 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 102.31 per share. | 05 Dec 2025 | 744 | 56,217 (0%) | 0% | 102.3 | 76,116 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 101.43 per share. | 05 Dec 2025 | 478 | 56,961 (0%) | 0% | 101.4 | 48,482 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 105.99 per share. | 05 Dec 2025 | 400 | 28,951 (0%) | 0% | 106.0 | 42,395 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 103.48 per share. | 05 Dec 2025 | 372 | 55,845 (0%) | 0% | 103.5 | 38,495 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 104.10 per share. | 05 Dec 2025 | 244 | 55,601 (0%) | 0% | 104.1 | 25,400 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 106.63 per share. | 05 Dec 2025 | 228 | 55,373 (0%) | 0% | 106.6 | 24,312 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 9,954 | 20,210 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 9,954 | 63,179 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.65 per share. | 01 Oct 2025 | 5,740 | 57,439 (0%) | 0% | 62.7 | 359,611 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 1,928 | 51,557 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Freeman Chris | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 1,928 | 7,714 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Freeman Chris | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 1,668 | 6,669 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 1,668 | 53,225 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2025 | 1,402 | 50,223 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2025 | 1,402 | 4,206 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.79 per share. | 15 Sep 2025 | 594 | 49,629 (0%) | 0% | 54.8 | 32,545 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 1,929 | 48,686 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 1,929 | 9,642 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 1,667 | 50,353 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 1,667 | 8,337 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.71 per share. | 01 Jul 2025 | 1,532 | 48,821 (0%) | 0% | 50.7 | 77,688 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 4,879 | 48,030 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 4,879 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.29 per share. | 15 Jun 2025 | 2,675 | 46,757 (0%) | 0% | 49.3 | 131,851 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 1,402 | 5,608 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 1,402 | 49,432 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,928 | 11,571 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,928 | 41,731 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,667 | 10,004 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,667 | 43,398 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 01 Apr 2025 | 1,106 | 42,292 (0%) | 0% | 42.5 | 46,972 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,401 | 40,190 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,401 | 7,010 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.89 per share. | 15 Mar 2025 | 387 | 39,803 (0%) | 0% | 42.9 | 16,598 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 23,145 | 23,145 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 15,430 | 15,430 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,686 | 11,376 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,686 | 40,355 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 01 Mar 2025 | 1,566 | 38,789 (0%) | 0% | 42.5 | 66,633 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 1,928 | 34,185 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 1,928 | 13,499 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 1,667 | 35,852 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 1,667 | 11,671 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.55 per share. | 01 Jan 2025 | 1,183 | 34,669 (0%) | 0% | 30.6 | 36,141 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 1,402 | 32,854 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 1,402 | 8,411 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 15 Dec 2024 | 597 | 32,257 (0%) | 0% | 34.8 | 20,752 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 45,246 | 45,246 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 30,164 | 30,164 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 6,569 | 13,338 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 6,569 | 35,072 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.12 per share. | 01 Oct 2024 | 3,620 | 31,452 (0%) | 0% | 22.1 | 80,074 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 1,929 | 28,503 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 1,929 | 15,427 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 1,402 | 9,813 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 1,402 | 27,171 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.79 per share. | 15 Sep 2024 | 597 | 26,574 (0%) | 0% | 26.8 | 15,994 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 1,928 | 26,527 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 1,928 | 17,356 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.26 per share. | 01 Jul 2024 | 758 | 25,769 (0%) | 0% | 28.3 | 21,421 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 5,523 | 11,215 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 5,523 | 27,469 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 4,879 | 21,946 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 4,879 | 4,879 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.21 per share. | 15 Jun 2024 | 2,870 | 24,599 (0%) | 0% | 30.2 | 86,703 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 1,929 | 19,284 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 1,929 | 16,502 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.25 per share. | 01 Apr 2024 | 531 | 15,971 (0%) | 0% | 20.3 | 10,753 | Common Stock |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 1,928 | 15,207 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 1,928 | 21,213 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Freeman Chris | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.05 per share. | 01 Jan 2024 | 634 | 14,573 (0%) | 0% | 27.1 | 17,150 | COMMON STOCK |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 29,861 | 29,861 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 19,907 | 19,907 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 4,879 | 9,040 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 4,879 | 9,758 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.86 per share. | 15 Jun 2023 | 1,346 | 7,694 (0%) | 0% | 37.9 | 50,960 | COMMON STOCK |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 25,107 | 25,107 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 16,738 | 16,738 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 61,708 | 61,708 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 30,854 | 30,854 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 4,879 | 14,637 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 4,879 | 4,879 (0%) | 0% | 0 | COMMON STOCK |